Syed M. Ishaq, MD (@syedishaqmd) 's Twitter Profile
Syed M. Ishaq, MD

@syedishaqmd

IM resident @SinaiBmoreIMres

ID: 1287007850

calendar_today21-03-2013 21:25:43

2,2K Tweet

1,1K Followers

2,2K Following

JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

In an analysis of 2,966 patients with atrial fibrillation age ≥80 years within a randomized trial, major bleeding events were lower with edoxaban 30 mg compared with either edoxaban 60 mg or warfarin, without an offsetting increase in ischemic events. ja.ma/3WsYTws

In an analysis of 2,966 patients with atrial fibrillation age ≥80 years within a randomized trial, major bleeding events were lower with edoxaban 30 mg compared with either edoxaban 60 mg or warfarin, without an offsetting increase in ischemic events. ja.ma/3WsYTws
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

Higher Lp(a) levels were associated with increased progression of coronary plaque burden and increased presence of low-density noncalcified plaque and pericoronary adipose tissue inflammation. ja.ma/4fiaK7C

Higher Lp(a) levels were associated with increased progression of coronary plaque burden and increased presence of low-density noncalcified plaque and pericoronary adipose tissue inflammation. 

ja.ma/4fiaK7C
Aamir Laghari , MD (@draamirlaghari) 's Twitter Profile Photo

While on night call, got a very young patient with syncope and after putting the probe on chest, first thing you see is really …an interesting case of effusive constrictive pericarditis 🫀 Similar case reported in JACC acc.org/Education-and-…

Prakash Upreti, MD (@prakashupretimd) 's Twitter Profile Photo

🎉 Excited to announce that 20+ abstracts from the MCA group have been accepted to the AHA conference in Chicago on Nov 18–20! Huge thanks to all the amazing group members for their hard work and dedication under the mentorship of Chadi Alraies, MD FACC FSCAI #AHA2024 #TeamMCA

🎉 Excited to announce that 20+ abstracts from the MCA group have been accepted to the AHA conference in Chicago on Nov 18–20! Huge thanks to all the amazing group members for their hard work and dedication under the mentorship of <a href="/chadialraies/">Chadi Alraies, MD FACC FSCAI</a>
#AHA2024 #TeamMCA
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

In this pooled analysis of PARADIGM-HF/PARAGON-HF RCTs, sacubitril/valsartan significantly reduced all-cause hospitalization in heart failure, particularly in patients with LVEF <60%, driven by decreased cardiopulmonary events. ja.ma/3Z6Zrto Muthu Vaduganathan #ESCCongress

In this pooled analysis of PARADIGM-HF/PARAGON-HF RCTs, sacubitril/valsartan significantly reduced all-cause hospitalization in heart failure, particularly in patients with LVEF &lt;60%, driven by decreased cardiopulmonary events. ja.ma/3Z6Zrto

<a href="/mvaduganathan/">Muthu Vaduganathan</a> #ESCCongress
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

From JAMA: Among patients who underwent major noncardiac surgery, renin-angiotensin system inhibitor continuation before surgery was not associated with a higher rate of postoperative complications than discontinuation. ja.ma/4e22mrI #ESCCongress

From <a href="/JAMA_current/">JAMA</a>: Among patients who underwent major noncardiac surgery, renin-angiotensin system inhibitor continuation before surgery was not associated with a higher rate of postoperative complications than discontinuation. ja.ma/4e22mrI 

#ESCCongress
Mark Mills (@drmarkmills) 's Twitter Profile Photo

Bye bye CHA2DS2-VASc score, hello CHA2DS2-VA score 🫀 (Problem is, they both sound identical when you pronounce them!) #ESCCongress

Bye bye CHA2DS2-VASc score, hello CHA2DS2-VA score 🫀

(Problem is, they both sound identical when you pronounce them!)

#ESCCongress
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

The OCEANIC-AF trial, comparing asundexian to apixaban in patients with atrial fibrillation was halted early due to a significantly higher incidence of stroke or systemic embolism in the asundexian group. The findings raise questions about the adequacy of factor XIa inhibition

The OCEANIC-AF trial, comparing asundexian to apixaban in patients with atrial fibrillation was halted early due to a significantly higher incidence of stroke or systemic embolism in the asundexian group. The findings raise questions about the adequacy of factor XIa inhibition
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

No need to fast before cardiac cath procedure, SCOFF trial shows. Download slides from SCOFF trial presented at #ESCCongress here clinicaltrialresults.org/wp-content/upl…

No need to fast before cardiac cath procedure, SCOFF trial shows. Download slides from SCOFF trial presented at #ESCCongress here clinicaltrialresults.org/wp-content/upl…
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Screening for AF using a 14-day, patch-based continuous ECG monitor in individuals aged ≥70 years increased detection of AF by 52%, and initiation of OAC, but did not reduce hospitalization for stroke #ESCCongress

Screening for AF using a 14-day, patch-based continuous ECG monitor in individuals aged ≥70 years increased detection of AF by 52%, and initiation of OAC, but did not reduce hospitalization for stroke #ESCCongress
Hany Ragy (@hragy) 's Twitter Profile Photo

In our cath lab during primary PCI we have a nurse by the patient’s head with visual and verbal contact at all time. Yesterday she alerted me that the patient will arrest moments before they did! When she said it the ECG and BP were still normal, I believe she saved the case.